|
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
LAMB2 DNA Sequencing Test
Test CodeCPT Codes
81407<br>Limited Access Code
Physician Attestation of Informed Consent
Preferred Specimen
Pediatric (0-3 years): 2 mL
Minimum Volume
Instructions
Informed consent required
Higher blood volumes ensure adequate DNA quantity, which varies with WBC, specimen condition, and need for confirmatory testing. Patients, 0-3 years have higher WBC, yielding more DNA per mL of blood.
Please label each specimen tube with two forms of patient identification. These forms of identification must also appear on the requisition form.
Shipping Conditions: Ship same day. Must arrive at Athena on a weekday
Transport Temperature
Specimen Stability
Refrigerated: 10 days
Frozen: Unacceptable
Methodology
Sanger Sequencing
FDA Status
This test was developed and its analytical performance characteristics have been determined by Athena Diagnostics. It has not been cleared or approved by FDA. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.
Setup Schedule
Reference Range
Clinical Significance
Disease(s) tested for: Nephrotic Syndrome
Detects mutations in the LAMB2 gene
Detects sequence variants in the LAMB2 gene. Truncating sequence variants lead to Pierson syndrome with nephrotic syndrome, diffuse mesangial sclerosis, distinct eye anomalies, and intellectual disability. Missense sequence variants are associated with variable symptoms ranging from isolated early onset nephrotic syndrome to intermediate phenotypes.